Finance
Markets
No recent trading data. The last price we hold for ABT is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

ABT

stock Healthcare Medical Devices
Abbott Laboratories
$86.99 +0.02 (+0.02%) Delayed · quoted 46d ago
Mixed 40% Slipping

What the indicators say

Bearish 0 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
44
0oversold 30overbought 70100

RSI 44 — soft momentum, not yet oversold.

EMA 21 $87.73
Below
Near-term trend is down
SMA 50 $93.09
Below
Medium-term trend is down
SMA 200 $115.95
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $89.98
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $86.72 High $88.07
Open
$87.03
+0.06%
Close
$87.03
+0.06%
52-week range where the price sits across its year
52w low $81.97 52w high $139.06
Current
$87.03
Prev close
$86.97
Volume 0.68× the 3-month average
0 avg 2× avg
Today
8.39M
3-mo avg
12.42M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 1696 days ago
Next expected
Jul 165 days ago

Recent earnings dates

  • Apr 16 96 days ago
  • Jan 22 180 days ago
  • Oct 15, 2025 279 days ago
  • Jul 17, 2025 369 days ago

Past earnings dates come from ABT’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), ABT’s fundamentals read as strong overall.

P/E ratio Strong
24.4x

At 24.4x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.76%

A 2.8% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
14.7%

A 14.7% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
12.5%

A 12.5% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
7.5%

A 7.5% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.58

At 1.58, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+5.7%

Revenue grew 5.7% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-51.3%

Net income fell 51.3% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $43.1B$43.7B$40.1B$42.0B$44.3B
Net income $7.1B$6.9B$5.7B$13.4B$6.5B
Diluted EPS $3.94$3.91$3.26$7.64$3.72
Dividend / share $1.92$2.08$2.24$2.40
Total assets $75.2B$74.4B$73.2B$81.4B$86.7B
Total liabilities
Shareholder equity $35.8B$36.7B$38.6B$47.7B$52.1B

Leadershipsynced from SEC 59d ago

  • Ford Robert B CHAIRMAN AND CEO · Director
  • Boudreau Philip P EVP AND CFO
  • Earnhardt Lisa D EVP AND GROUP PRESIDENT
  • Mccoy John A. Jr. VICE PRESIDENT AND CONTROLLER
  • Moreland Mary K EXECUTIVE VICE PRESIDENT
  • Morrone Louis H. EXECUTIVE VICE PRESIDENT
  • Orville Jacob A Senior Vice President
  • Salvadori Daniel Gesua Sive EVP AND GROUP PRESIDENT
  • Scoggins Christopher J EXECUTIVE VICE PRESIDENT
  • Shroff Eric Senior Vice President
  • Ahuja Nita Director
  • Alpern Robert J Director
  • Babineaux-Fontenot Claire Director
  • Blount Sally E. Director
  • Conroy Kevin T Director
  • Gonzalez Patricia Paola Director
  • Kumbier Michelle Director
  • Mcdew Darren W Director
  • Mckinstry Nancy Director
  • O'Grady Michael Director
  • Roman Michael F Director
  • Starks Daniel J Director
  • Stratton John G Director

Officers and board are drawn from ABT’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$2.36
2026 so far
$1.262 payments
2026 projected
$2.52+6.8% vs 2025

Projection scales ABT’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Apr 15 $0.63
  • Jan 15 $0.63
  • Oct 15, 2025 $0.59
  • Jul 15, 2025 $0.59
  • Apr 15, 2025 $0.59
  • Jan 15, 2025 $0.59
  • Oct 15, 2024 $0.55
  • Jul 15, 2024 $0.55
  • Apr 12, 2024 $0.55
  • Jan 11, 2024 $0.55
  • Oct 12, 2023 $0.51
  • Jul 13, 2023 $0.51
  • Apr 13, 2023 $0.51
  • Jan 12, 2023 $0.51
  • Oct 13, 2022 $0.47
  • Jul 14, 2022 $0.47
  • Apr 13, 2022 $0.47
  • Jan 13, 2022 $0.47
  • Oct 14, 2021 $0.45
  • Jul 14, 2021 $0.45

Recent SEC filingssynced from SEC 53d ago